Raras
Buscar doenças, sintomas, genes...
Síndrome de blefarofimose-ptose-epicanto inverso
ORPHA:126CID-10 · Q10.3CID-11 · LD21.YOMIM 110100DOENÇA RARA

A Síndrome de Blefarofimose, Ptose e Epicanto Inverso (BPES) é uma condição dos olhos (oftalmológica) caracterizada por: pálpebras mais curtas ou com uma abertura menor do que o normal (blefarofimose), pálpebra caída (ptose), uma dobra de pele no canto interno do olho que aponta para baixo (epicanto inverso), e maior distância entre os cantos internos dos olhos (telecanto). Essa síndrome pode ser associada (tipo I) ou não (tipo II) à falência ovariana prematura (FOP).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Síndrome de Blefarofimose, Ptose e Epicanto Inverso (BPES) é uma condição dos olhos (oftalmológica) caracterizada por: pálpebras mais curtas ou com uma abertura menor do que o normal (blefarofimose), pálpebra caída (ptose), uma dobra de pele no canto interno do olho que aponta para baixo (epicanto inverso), e maior distância entre os cantos internos dos olhos (telecanto). Essa síndrome pode ser associada (tipo I) ou não (tipo II) à falência ovariana prematura (FOP).

Publicações científicas
207 artigos
Último publicado: 2026 Jan 19

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Antenatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q10.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
6 sintomas
👁️
Olhos
5 sintomas
📏
Crescimento
3 sintomas
🫘
Rins
1 sintomas
👂
Ouvidos
1 sintomas
🧠
Neurológico
1 sintomas

+ 11 sintomas em outras categorias

Características mais comuns

100%prev.
Ptose
Frequência: 9/9
100%prev.
Blefarofimose
Frequência: 9/9
100%prev.
Fissura palpebral estreita
Frequência: 4/4
100%prev.
Telecanto
Frequência: 4/4
100%prev.
Epicanto inverso
Frequência: 9/9
90%prev.
Ponte nasal deprimida
Muito frequente (99-80%)
29sintomas
Muito frequente (7)
Frequente (3)
Ocasional (3)
Muito raro (2)
Sem dados (14)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 29 características clínicas mais associadas, ordenadas por frequência.

PtosePtosis
Frequência: 9/9100%
BlefarofimoseBlepharophimosis
Frequência: 9/9100%
Fissura palpebral estreitaNarrow palpebral fissure
Frequência: 4/4100%
TelecantoTelecanthus
Frequência: 4/4100%
Epicanto inversoEpicanthus inversus
Frequência: 9/9100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico207PubMed
Últimos 10 anos68publicações
Pico201812 papers
Linha do tempo
2026Hoje · 2026📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

FOXL2Forkhead box protein L2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional regulator. Critical factor essential for ovary differentiation and maintenance, and repression of the genetic program for somatic testis determination. Prevents trans-differentiation of ovary to testis through transcriptional repression of the Sertoli cell-promoting gene SOX9 (By similarity). Has apoptotic activity in ovarian cells. Suppresses ESR1-mediated transcription of PTGS2/COX2 stimulated by tamoxifen (By similarity). Is a regulator of CYP19 expression (By similarity). Par

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
SUMOylation of transcription factors
MECANISMO DE DOENÇA

Blepharophimosis, ptosis, and epicanthus inversus syndrome

A disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold curving in the mediolateral direction, inferior to the inner canthus. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects.

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
102.0 TPM
Cervix Endocervix
31.4 TPM
Cervix Ectocervix
26.6 TPM
Fallopian Tube
25.6 TPM
Pituitária
19.0 TPM
OUTRAS DOENÇAS (6)
premature ovarian failure 3blepharophimosis, ptosis, and epicanthus inversus syndromemaligant granulosa cell tumor of ovaryblepharophimosis-ptosis-epicanthus inversus syndrome type 1
HGNC:1092UniProt:P58012

Variantes genéticas (ClinVar)

214 variantes patogênicas registradas no ClinVar.

🧬 FOXL2: NM_023067.4(FOXL2):c.269T>C (p.Phe90Ser) ()
🧬 FOXL2: NM_023067.4(FOXL2):c.608C>A (p.Ser203Ter) ()
🧬 FOXL2: NM_023067.4(FOXL2):c.1032dup (p.Phe345fs) ()
🧬 FOXL2: NM_023067.4(FOXL2):c.1095del (p.Ser365fs) ()
🧬 FOXL2: NM_023067.4(FOXL2):c.277A>T (p.Lys93Ter) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de blefarofimose-ptose-epicanto inverso

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
68 papers (10 anos)
#1

Genetic and Clinical Features of FOXL2-Associated Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Based on 11 Chinese Families and Literature Review.

American journal of medical genetics. Part A2026 Jan 19

Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), caused by FOXL2 variants, has been divided into two subtypes by eyelid abnormalities with (BPES-I) or without (BPES-II) primary ovarian insufficiency (POI). This study investigated the genetic and phenotypic characteristics of FOXL2-associated BPES and their genotype-phenotype correlations. FOXL2 variants were identified by in-house next-generation sequencing and compared with public databases. Clinical features were also summarized. Eleven FOXL2 variants, including four novel, were detected in 11 families from our cohort. Based on literature, 273 FOXL2 pathogenic/likely pathogenic variants were reviewed in 650 patients from 548 families. Nearly half (47.6%, 130/273) of the variants were truncation. The most frequent (24.0%, 132/549) variant was p.A225_A234dup. In the polyalanine tract, variants leading to the deletion of 1-10 or expansion/insertion of 2 alanine residues were likely benign, whereas variants causing the expansion/insertion of 10-15 alanine residues were pathogenic. The proportion of truncation variants was significantly higher in patients with BPES-I (73.8%, 48/65) than in those with BPES-II (19.6%, 19/97). In conclusion, the pathogenicity of in-frame variants within the polyalanine tract was associated with the number of polyalanine residues. Truncation variants were frequently linked to the severe phenotype (BPES-I), highlighting their potential value in clinical diagnosis and patient management, particularly for preventing or treating POI.

#2

Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) due to polyAla site variant in FOXL2: diagnostic challenges with NGS.

BMJ case reports2025 Aug 26

This report presents a case of blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) identified in a term neonate. This patient presented with the four typical ophthalmic signs: short horizontal palpebral fissures (blepharophimosis), impaired levator palpebrae superioris muscle function leading to drooping of upper eyelids (ptosis), skin folding on the medial lower eyelid ascending to the upper eyelid (epicanthus inversus) and increased medial intercanthal distance (telecanthus). On genetic analysis, a polyalanine (polyAla) tract expansion in the FOXL2 gene was identified. Through this report, we highlight the importance of understanding the limitations of different genetic tests when investigating diseases with polyalanine tract expansion mutations such as BPES.

#3

One-stage versus two-stage surgical correction of blepharophimosis-ptosis-epicanthus inversus syndrome: a retrospective comparative study.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus2025 Dec

To compare the surgical outcomes of one-stage and two-stage correction of blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) in children <3 years of age. This retrospective comparative study included children <3 years with BPES who underwent surgical correction at Cairo University. Medial canthoplasty was performed using the Y-V, C-U, or five-flap technique, while ptosis was corrected by frontalis suspension using polytetrafluoroethylene sling. Patients were divided into one-stage and two-stage groups. Surgical outcomes were assessed based on horizontal palpebral fissure length (HPFL), interpalpebral fissure height (IPFH), inner intercanthal distance (IICD) and IICD/HPFL ratio. Twenty-four patients were included: 11 in the one-stage group and 13 in the two-stage group. Both groups showed significant postoperative improvements in HPFL, IPFH, IICD and IICD/HPFL (P < 0.005), with no statistically significant difference between them. The two-stage group had a higher proportion of patients with good blepharophimosis outcome (46% vs 27%), whereas the one-stage group showed a higher proportion of good ptosis outcomes (64% vs 46%); however, these differences were not statistically significant. Complications were minimal and comparable between both groups. Outcomes of one- and two-stage approaches were comparable in our cohort. One-stage correction may be preferable in patients with severe ptosis, although two-stage repair may better address severe blepharophimosis.

#4

A rare case of Blepharophimosis-Ptosis-Epicanthus inversus syndrome (BPES) associated with keratoconus: a multidisciplinary approach to diagnosis and management.

BMC ophthalmology2025 Oct 10

Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome (BPES) is a rare congenital condition typically associated with mutations in the FOXL2 gene. It is characterized by eyelid malformations and, in some cases, premature ovarian insufficiency. Although visual complications such as astigmatism and amblyopia are well recognized, an association between BPES-like features and keratoconus has not been previously reported. We report a 41-year-old Saudi female presenting with progressive visual decline and congenital eyelid abnormalities. Clinical evaluation revealed features consistent with BPES, and corneal topography confirmed bilateral keratoconus. Genetic testing identified a homozygous pathogenic variant in the COLEC10 gene, with no FOXL2 mutations detected. A multidisciplinary management plan involving oculoplasty consult, corneal rehabilitation, and endocrine evaluation was implemented. This case represents a novel association between a COLEC10 mutation and a BPES-like phenotype with coexisting keratoconus. The findings suggest a potential genetic and mechanical basis for corneal ectasia in patients with congenital eyelid anomalies. The absence of FOXL2 involvement emphasizes the importance of broad genetic testing in atypical presentations. Routine corneal imaging and comprehensive genetic analysis should be considered in patients with syndromic eyelid malformations. This case expands the clinical spectrum of COLEC10-related disorders and supports the need for further research into its role in ocular development and corneal biomechanics. The online version contains supplementary material available at 10.1186/s12886-025-04368-2.

#5

Chromosome 3q22.2-q26.2 Interstitial Deletion in a Patient With Wisconsin Syndrome, Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Dandy-Walker Malformation, Pierre Robin Sequence, and Recurrent Infections.

American journal of medical genetics. Part A2025 Oct

Wisconsin syndrome is a very rare genetic condition characterized by coarse facies, prominent nasal tip, bushy high arched/upsweeping eyebrows, and a full/everted lower lip. Deletion of chromosome 3q24q25 region is considered critical for its manifestation. Deletion of the adjoining chromosome region 3q24 is associated with Dandy-Walker malformation, while 3q22.3 deletion is associated with blepharophimosis-ptosis-epicanthus inversus syndrome. Here, we report an individual with chromosome 3q22.2-q26.2 interstitial deletion presenting with Wisconsin syndrome, blepharophimosis-ptosis-epicanthus inversus syndrome, Dandy-Walker malformation, Pierre Robin sequence, global developmental delays, and recurrent infections. This is the largest contiguous gene deletion reported in this region, and the combination of clinical features seen in this individual has not been reported before. Additionally, we propose that STAG1 is a candidate gene for recurrent infections in addition to cognitive impairment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC121 artigos no totalmostrando 68

2026

Genetic and Clinical Features of FOXL2-Associated Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Based on 11 Chinese Families and Literature Review.

American journal of medical genetics. Part A
2025

One-stage versus two-stage surgical correction of blepharophimosis-ptosis-epicanthus inversus syndrome: a retrospective comparative study.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

A rare case of Blepharophimosis-Ptosis-Epicanthus inversus syndrome (BPES) associated with keratoconus: a multidisciplinary approach to diagnosis and management.

BMC ophthalmology
2025

Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) due to polyAla site variant in FOXL2: diagnostic challenges with NGS.

BMJ case reports
2025

Chromosome 3q22.2-q26.2 Interstitial Deletion in a Patient With Wisconsin Syndrome, Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Dandy-Walker Malformation, Pierre Robin Sequence, and Recurrent Infections.

American journal of medical genetics. Part A
2025

Functional analysis of a novel FOXL2 mutation in blepharophimosis, ptosis, and epicanthus inversus syndrome type II and elucidation of the genotype-phenotype correlation.

Human genomics
2024

Corrigendum: Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome.

Frontiers in genetics
2025

Lambda-double-fixation for medial epicanthoplasty in Blepharophimosis - Ptosis - Epicanthus Inversus Syndrome.

Orbit (Amsterdam, Netherlands)
2024

Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome.

Frontiers in genetics
2024

Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly.

The Journal of craniofacial surgery
2023

FOXL2: a gene central to ovarian function.

Journal of clinical pathology
2024

Improvement of 1-Stage Comprehensive Operation Technique for Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.

Plastic and reconstructive surgery
2023

Identification and functional analyses of a novel FOXL2 pathogenic variant causing blepharophimosis, ptosis, and epicanthus inversus syndrome.

International journal of ophthalmology
2023

Evaluation of ovarian reserve in young females with non-iatrogenic ovarian insufficiency to establish criteria for ovarian tissue cryopreservation.

Reproductive biomedicine online
2023

Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants.

Journal of ovarian research
2022

Clinical and genetic studies of 17 Han Chinese pedigrees and 31 sporadic patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Molecular vision
2022

Surgical outcome of epicanthus and telecanthus correction by C-U medial canthoplasty with lateral canthoplasty in treatment of Blepharophimosis syndrome.

BMC ophthalmology
2022

Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With FOXL2 Mutations.

Frontiers in endocrinology
2022

Bilateral cataract in a child with blepharophimosis-ptosis-epicanthus inversus syndrome: A surgical challenge.

International journal of surgery case reports
2021

ITGB5 mutation discovered in a Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome.

Open life sciences
2023

Association between blepharophimosis-ptosis-epicanthus inversus syndrome and lacrimal system anomalies.

Orbit (Amsterdam, Netherlands)
2021

Planned oocyte cryopreservation in women with blepharophimosis-ptosis-epicanthus inversus syndrome: a case series.

F&amp;S reports
2022

A Novel Forkhead Box L2 Missense Mutation, c.1068G>C, in a Chinese Family With Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome.

The Journal of craniofacial surgery
2021

Follicular Dowling-Degos Disease and Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome: A Chance or Significant Association.

Indian journal of dermatology
2021

"Blepharophimosis-plus" syndromes: Frequency of systemic genetic disorders that also include blepharophimosis.

Clinical &amp; experimental ophthalmology
2021

Identification of a novel FOXL2 mutation in a fourth-generation Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome.

International journal of ophthalmology
2021

Functional Studies of Novel FOXL2 Variants in Chinese Families With Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.

Frontiers in genetics
2021

Management of congenital lacrimal gland agenesis in a patient with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).

Journal francais d'ophtalmologie
2021

[Management of blepharophimosis, ptosis, epicanthus inversus syndrome at a referral center in Tunisia].

Journal francais d'ophtalmologie
2020

Wiedemann-steiner syndrome with a de novo mutation in KMT2A: A case report.

Medicine
2020

A novel FOXL2 mutation in two infertile patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Journal of assisted reproduction and genetics
2021

A rare association of blepharophimosis-ptosis-epicanthus inversus case with congenital nasolacrimal duct obstruction.

European journal of ophthalmology
2019

Premature ovarian insufficiency as a variable feature of blepharophimosis, ptosis, and epicanthus inversus syndrome associated with c.223C > T p.(Leu75Phe) FOXL2 mutation: a case report.

BMC medical genetics
2019

New STAT3-FOXL2 pathway and its function in cancer cells.

BMC molecular and cell biology
2019

Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome: New Report with a 197-kb Deletion Upstream of FOXL2 and Review of the Literature.

Molecular syndromology
2019

Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus.

Gene
2018

Genomic Disruption of FOXL2 in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type 2: A Novel Deletion-Insertion Compound Mutation.

Chinese medical journal
2018

Genetic and Functional Analyses of Two Missense Mutations in the Transcription Factor FOXL2 in Two Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.

Genetic testing and molecular biomarkers
2018

[Analysis of FOXL2 gene mutation and genotype-phenotype correlation in a Chinese pedigree affected with blepharophimosis-ptosis-epicanthus inversus syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2018

Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome.

BMC medical genetics
2018

[Effectiveness of levator muscle resection combined with Mustarde's double Z-plasty for blepharophimosis-ptosis-epicanthus inversus syndrome].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2018

Blepharophimosis-ptosis-epicanthus inversus syndrome caused by a 54-kb microdeletion in a FOXL2 cis-regulatory element.

Clinical dysmorphology
2018

Ultrasound biomicroscopy image patterns in normal upper eyelid and congenital ptosis in the Indian population.

Indian journal of ophthalmology
2018

Loss of Function of the Nuclear Receptor NR2F2, Encoding COUP-TF2, Causes Testis Development and Cardiac Defects in 46,XX Children.

American journal of human genetics
2018

[Identification of de novo chromosomal structural abnormalities using whole genome sequencing].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2018

Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.

Molecular genetics &amp; genomic medicine
2018

A Novel FOXL2 Mutation Implying Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
2018

SIX2 gene haploinsufficiency leads to a recognizable phenotype with ptosis, frontonasal dysplasia, and conductive hearing loss.

Clinical dysmorphology
2017

Re: Duarte et al.: Lacrimal gland involvement in blepharophimosis-ptosis-epicanthus inversus syndrome (Ophthalmology. 2017;124:399-406).

Ophthalmology
2017

Functional Analysis of a Novel FOXL2 Indel Mutation in Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I.

International journal of biological sciences
2017

Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.

Molecular medicine reports
2016

De Novo 3q22.3q24 Microdeletion in a Patient With Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Dandy-Walker Malformation, and Wisconsin Syndrome.

Child neurology open
2017

Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene.

American journal of medical genetics. Part A
2016

[Blepharophimosis-ptosis-epicanthus inversus syndrome].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
2017

Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) Type 1 in an Indian Family.

Journal of the ASEAN Federation of Endocrine Societies
2017

Lacrimal Gland Involvement in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.

Ophthalmology
2016

Unilateral anterior persistent fetal vasculature in a child with blepharophimosis-ptosis-epicanthus inversus syndrome: A surgical challenge.

Indian journal of ophthalmology
2016

Analysis of FOXL2 detects three novel mutations and an atypical phenotype of blepharophimosis-ptosis-epicanthus inversus syndrome.

Clinical &amp; experimental ophthalmology
2017

The Emerging Role of FOXL2 in Regulating the Transcriptional Activation Function of Estrogen Receptor β: An Insight Into Ovarian Folliculogenesis.

Reproductive sciences (Thousand Oaks, Calif.)
2017

Blepharophimosis Ptosis Epicanthus Inversus Syndrome With Congenital Hypothyroidism and Brachydactyly in a 7-Year-Old Girl.

Ophthalmic plastic and reconstructive surgery
2015

[Clinical diagnose and significance of congenital sensorineural hearing loss combined with BPES].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2015

Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.

BMC medical genetics
2015

A Rare Association of Childhood Alopecia Areata and Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome: Successfully Treated with Diphenylcyclopropenone.

International journal of trichology
2015

FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice.

BMC developmental biology
2016

Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

Journal of endocrinological investigation
2015

A Modified One-Stage Early Correction of Blepharophimosis Syndrome Using Tutopatch Slings.

Orbit (Amsterdam, Netherlands)
2015

A novel FOXL2 gene mutation and BMP15 variants in a woman with primary ovarian insufficiency and blepharophimosis-ptosis-epicanthus inversus syndrome.

Menopause (New York, N.Y.)
2015

A novel FOXL2 mutation in a Chinese family with blepharophimosis, ptosis, epicanthus inversus syndrome.

Human genome variation
Ver todos os 121 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de blefarofimose-ptose-epicanto inverso.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de blefarofimose-ptose-epicanto inverso

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Genetic and Clinical Features of FOXL2-Associated Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Based on 11 Chinese Families and Literature Review.
    American journal of medical genetics. Part A· 2026· PMID 41555764mais citado
  2. Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) due to polyAla site variant in FOXL2: diagnostic challenges with NGS.
    BMJ case reports· 2025· PMID 40858345mais citado
  3. One-stage versus two-stage surgical correction of blepharophimosis-ptosis-epicanthus inversus syndrome: a retrospective comparative study.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus· 2025· PMID 41265558mais citado
  4. A rare case of Blepharophimosis-Ptosis-Epicanthus inversus syndrome (BPES) associated with keratoconus: a multidisciplinary approach to diagnosis and management.
    BMC ophthalmology· 2025· PMID 41073991mais citado
  5. Chromosome 3q22.2-q26.2 Interstitial Deletion in a Patient With Wisconsin Syndrome, Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome, Dandy-Walker Malformation, Pierre Robin Sequence, and Recurrent Infections.
    American journal of medical genetics. Part A· 2025· PMID 40464571mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:126(Orphanet)
  2. OMIM OMIM:110100(OMIM)
  3. MONDO:0007201(MONDO)
  4. GARD:23(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q18554819(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de blefarofimose-ptose-epicanto inverso
Compêndio · Raras BR

Síndrome de blefarofimose-ptose-epicanto inverso

ORPHA:126 · MONDO:0007201
Prevalência
Unknown
Herança
Autosomal dominant, Not applicable
CID-10
Q10.3 · Outras malformações congênitas das pálpebras
CID-11
Início
Antenatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0220663
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades